BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21605113)

  • 1. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
    Coppieters KT; Amirian N; von Herrath MG
    Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
    Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
    Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
    Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
    J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
    Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
    Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    Lieberman SM; Takaki T; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Dec; 173(11):6727-34. PubMed ID: 15557165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
    Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
    J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.
    Babad J; Mukherjee G; Follenzi A; Ali R; Roep BO; Shultz LD; Santamaria P; Yang OO; Goldstein H; Greiner DL; DiLorenzo TP
    Clin Exp Immunol; 2015 Mar; 179(3):398-413. PubMed ID: 25302633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
    Jarchum I; Nichol L; Trucco M; Santamaria P; DiLorenzo TP
    Clin Immunol; 2008 Jun; 127(3):359-65. PubMed ID: 18358785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
    Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
    Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell cross-presentation of autologous antigen precipitates diabetes.
    Mariño E; Tan B; Binge L; Mackay CR; Grey ST
    Diabetes; 2012 Nov; 61(11):2893-905. PubMed ID: 22829452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
    Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
    PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.